EPHB2 and melanoma: Despite some promising results with a drug‐conjugated Ab raised against EPHB2, which is expressed in melanomas, neuroblastomas, gastric, lung, and colon cancers,43, 44, 45, 46 which could induce cell death in EPHB2 expressing cells both in vitro and in vivo,47 no clinical data has been reported yet.